Clinical Trial Update: Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating saxagliptin with vitamin D3 for preserving β cell function in adults with Type 1 diabetes (latent autoimmune) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Latent Autoimmune Diabetes
• Type 1 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED